INM InMed Pharmaceuticals Inc.
$1.29▼ -1.53%
Healthcare
Other
After hours
$1.22▼ -5.40%
Sep 11, 5:58 PM ET
Volume 21.9K
Avg Volume (10D) 53.8K
Key Metrics & Fundamentals
Market Cap
$7.09M
P/E Ratio
–
Div Yield
–%
52W Range
0.58 - 2.50
% vs 50 MA
-13.91%
% vs 200 MA
9.44%
RSI-14
37.2
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.36
Free Cash Flow
-$2.96M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.92M
COGS
–
Operating Exp
$3.21M
Operating Income
-$3.21M
EBIT
-$3.21M
Pretax Income
-$4.84M
Net Income
-$5.84M
Price & Volume History
Loading chart…
Recent News
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update
TMX Newsfile · Sep 9, 2026 8:30 PM
Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline
PR Newswire · Jul 22, 2026 11:00 AM
InMed Pharmaceuticals Amends Deal With Mentari Therapeutics
MT Newswires · Jul 7, 2026 7:40 AM
InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4
TMX Newsfile · Jul 6, 2026 10:20 PM
Financial Overview - Income Statement
Quarterly
Dec 2025
See INM's money flow as a full page
Social Sentiment
No Reddit posts found for INM.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.